Citation Impact
Citing Papers
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
2012 StandoutScience
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
MicroRNA-155 is induced during the macrophage inflammatory response
2007 StandoutNobel
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Cancer statistics, 2020
2020 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture
2002
Inflammation and cancer
2002 StandoutNature
Prognostic markers in renal cell carcinoma
2007
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Human tumor antigens recognized by T-cells
1997
Dendritic cells and tumor immunity
2001
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
1999 StandoutNobel
CpG-DNA aided cross-presentation of soluble antigens by dendritic cells
2002
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
2003
A loss-of-function RNA interference screen for molecular targets in cancer
2006 Nature
Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
1998
Cancer statistics for Hispanics/Latinos, 2012
2012
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
2013
Direct and indirect T cell priming by dendritic cell vaccines
1999
Point-of-care immunotesting: Approaching the analytical performance of central laboratory methods
2005
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
2012
Dendritic Cells
1999
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Spinning molecular immunology into successful immunotherapy
2002
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
2000 StandoutNobel
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma
2013
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells
2000
Dendritic Cell Vaccines for Cancer Immunotherapy
1999
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune Responses
2000
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
1998
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.
1997
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
1999 StandoutNobel
Generation of Melanoma-Specific Cytotoxic T Lymphocytes by Dendritic Cells Transduced with a MART-1 Adenovirus
1998
Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue
1998
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
Retrovirally Transduced Human Dendritic Cells Express a Normal Phenotype and Potent T-Cell Stimulatory Capacity
1997
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity
1997
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
2000 StandoutScienceNobel
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
1999 StandoutScience
Immunobiology of Dendritic Cells
2000 Standout
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells
1998
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells
1998
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation
1999 StandoutScience
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of John S. Lam being referenced
Novel approaches in the therapy of metastatic renal cell carcinoma
2005
Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma
2007
Is Hispanic Race an Independent Risk Factor for Pathological Stage in Patients Undergoing Radical Prostatectomy?
2003
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
2006
IS HISPANIC RACE AN IMPORTANT PREDICTOR OF TREATMENT FAILURE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE CANCER?
2004
Utilization, Reliability, and Clinical Impact of Point-of-Care Testing during Critical Care Transport: Six Years of Experience
2003
POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM
2005
Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
2005
Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
1996
Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases
1997
RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY
2005